Morgane Rolland

Characterisation of an Irish caprine lentivirus strain--SRLV phylogeny revisited.

Establishment and characterization of a goat synovial membrane cell line susceptible to small ruminant lentivirus infection.

Coping with viral diversity in HIV vaccine design.

Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.

HIV-1 over time: fitness loss or robustness gain?

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

HIV-1 group M conserved elements vaccine.

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.

Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein.

HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.

Comparison of immunogen designs that optimize peptide coverage: reply to Fischer et al.

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.

Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design.

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses.

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.

Viral evolution and escape during acute HIV-1 infection.

Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.

Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.

Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.

Measurements of immune responses for establishing correlates of vaccine protection against HIV.

Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.

Definition of the viral targets of protective HIV-1-specific T cell responses.

CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.

HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.

HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.

Sieve analysis in HIV-1 vaccine efficacy trials.

Translational research insights from completed HIV vaccine efficacy trials.

Fitness costs of mutations at the HIV-1 capsid hexamerization interface.

Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses.

Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.

Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines.

HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.

CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.

Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.

Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.

Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.